nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—HTR7—coronary artery disease	0.155	0.665	CbGaD
Risperidone—HTR2A—coronary artery disease	0.0782	0.335	CbGaD
Risperidone—HTR1B—Penbutolol—coronary artery disease	0.0387	0.0947	CbGbCtD
Risperidone—HTR1A—Penbutolol—coronary artery disease	0.0242	0.0593	CbGbCtD
Risperidone—CYP3A7—Eplerenone—coronary artery disease	0.0156	0.0381	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0156	0.0381	CbGbCtD
Risperidone—ABCB1—Ticagrelor—coronary artery disease	0.0132	0.0324	CbGbCtD
Risperidone—CYP3A5—Clopidogrel—coronary artery disease	0.0126	0.0308	CbGbCtD
Risperidone—CYP3A5—Eplerenone—coronary artery disease	0.0117	0.0286	CbGbCtD
Risperidone—CYP3A7—Simvastatin—coronary artery disease	0.01	0.0246	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.01	0.0246	CbGbCtD
Risperidone—CYP3A7—Lovastatin—coronary artery disease	0.00982	0.024	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00982	0.024	CbGbCtD
Risperidone—KCNH2—purkinje fiber—coronary artery disease	0.00908	0.173	CbGeAlD
Risperidone—CYP3A7—Atorvastatin—coronary artery disease	0.00894	0.0219	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00894	0.0219	CbGbCtD
Risperidone—ABCB1—Perindopril—coronary artery disease	0.00818	0.02	CbGbCtD
Risperidone—ABCB1—Clopidogrel—coronary artery disease	0.00818	0.02	CbGbCtD
Risperidone—CYP3A5—Rosuvastatin—coronary artery disease	0.0081	0.0198	CbGbCtD
Risperidone—CYP3A4—Ticagrelor—coronary artery disease	0.00793	0.0194	CbGbCtD
Risperidone—CYP3A5—Simvastatin—coronary artery disease	0.00753	0.0184	CbGbCtD
Risperidone—CYP3A5—Pravastatin—coronary artery disease	0.00736	0.018	CbGbCtD
Risperidone—CYP3A5—Lovastatin—coronary artery disease	0.00736	0.018	CbGbCtD
Risperidone—ABCB1—Pitavastatin—coronary artery disease	0.00715	0.0175	CbGbCtD
Risperidone—ABCB1—Telmisartan—coronary artery disease	0.00715	0.0175	CbGbCtD
Risperidone—CYP3A4—Fenofibrate—coronary artery disease	0.00707	0.0173	CbGbCtD
Risperidone—ABCB1—Enalapril—coronary artery disease	0.00677	0.0166	CbGbCtD
Risperidone—ABCB1—Lisinopril—coronary artery disease	0.00677	0.0166	CbGbCtD
Risperidone—CYP3A5—Atorvastatin—coronary artery disease	0.00671	0.0164	CbGbCtD
Risperidone—CYP3A5—Losartan—coronary artery disease	0.00613	0.015	CbGbCtD
Risperidone—HTR2B—cardial valve—coronary artery disease	0.00586	0.112	CbGeAlD
Risperidone—CYP2D6—Niacin—coronary artery disease	0.00584	0.0143	CbGbCtD
Risperidone—ABCB1—Timolol—coronary artery disease	0.00576	0.0141	CbGbCtD
Risperidone—CYP3A4—Gemfibrozil—coronary artery disease	0.00565	0.0138	CbGbCtD
Risperidone—CYP2D6—Timolol—coronary artery disease	0.00543	0.0133	CbGbCtD
Risperidone—ABCB1—Ezetimibe—coronary artery disease	0.00527	0.0129	CbGbCtD
Risperidone—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00513	0.0126	CbGbCtD
Risperidone—ABCB1—Captopril—coronary artery disease	0.00507	0.0124	CbGbCtD
Risperidone—CYP3A4—Clopidogrel—coronary artery disease	0.0049	0.012	CbGbCtD
Risperidone—ABCB1—Simvastatin—coronary artery disease	0.0049	0.012	CbGbCtD
Risperidone—ABCB1—Lovastatin—coronary artery disease	0.00479	0.0117	CbGbCtD
Risperidone—ABCB1—Pravastatin—coronary artery disease	0.00479	0.0117	CbGbCtD
Risperidone—CYP2D6—Captopril—coronary artery disease	0.00478	0.0117	CbGbCtD
Risperidone—KCNH2—endocardium—coronary artery disease	0.00468	0.0893	CbGeAlD
Risperidone—CYP2D6—Simvastatin—coronary artery disease	0.00462	0.0113	CbGbCtD
Risperidone—CYP3A4—Eplerenone—coronary artery disease	0.00455	0.0111	CbGbCtD
Risperidone—CYP2D6—Lovastatin—coronary artery disease	0.00452	0.0111	CbGbCtD
Risperidone—CYP2D6—Pravastatin—coronary artery disease	0.00452	0.0111	CbGbCtD
Risperidone—ABCB1—Atorvastatin—coronary artery disease	0.00437	0.0107	CbGbCtD
Risperidone—CYP2D6—Atorvastatin—coronary artery disease	0.00411	0.0101	CbGbCtD
Risperidone—CYP3A4—Enalapril—coronary artery disease	0.00406	0.00994	CbGbCtD
Risperidone—ABCB1—Losartan—coronary artery disease	0.00399	0.00977	CbGbCtD
Risperidone—CYP3A4—Ezetimibe—coronary artery disease	0.00316	0.00773	CbGbCtD
Risperidone—CYP3A4—Rosuvastatin—coronary artery disease	0.00316	0.00773	CbGbCtD
Risperidone—CYP3A4—Simvastatin—coronary artery disease	0.00293	0.00718	CbGbCtD
Risperidone—CYP3A4—Pravastatin—coronary artery disease	0.00287	0.00703	CbGbCtD
Risperidone—CYP3A4—Lovastatin—coronary artery disease	0.00287	0.00703	CbGbCtD
Risperidone—CYP3A4—Atorvastatin—coronary artery disease	0.00262	0.0064	CbGbCtD
Risperidone—CYP3A4—Losartan—coronary artery disease	0.00239	0.00586	CbGbCtD
Risperidone—HTR7—pulmonary artery—coronary artery disease	0.00203	0.0388	CbGeAlD
Risperidone—HTR7—sympathetic nervous system—coronary artery disease	0.00198	0.0377	CbGeAlD
Risperidone—HTR2A—arteriole—coronary artery disease	0.00193	0.0369	CbGeAlD
Risperidone—HTR7—vagus nerve—coronary artery disease	0.00191	0.0365	CbGeAlD
Risperidone—HTR7—vein—coronary artery disease	0.00185	0.0353	CbGeAlD
Risperidone—HTR7—autonomic nervous system—coronary artery disease	0.00133	0.0254	CbGeAlD
Risperidone—HTR2A—pulmonary artery—coronary artery disease	0.00127	0.0242	CbGeAlD
Risperidone—HTR2A—sympathetic nervous system—coronary artery disease	0.00123	0.0235	CbGeAlD
Risperidone—HTR2A—vagus nerve—coronary artery disease	0.00119	0.0228	CbGeAlD
Risperidone—HTR2A—vein—coronary artery disease	0.00115	0.022	CbGeAlD
Risperidone—HTR1B—artery—coronary artery disease	0.000977	0.0186	CbGeAlD
Risperidone—HTR1D—artery—coronary artery disease	0.000946	0.0181	CbGeAlD
Risperidone—DRD4—heart—coronary artery disease	0.000882	0.0168	CbGeAlD
Risperidone—HTR2A—autonomic nervous system—coronary artery disease	0.000829	0.0158	CbGeAlD
Risperidone—HTR7—artery—coronary artery disease	0.000753	0.0144	CbGeAlD
Risperidone—H1F0—cardiac ventricle—coronary artery disease	0.000685	0.0131	CbGeAlD
Risperidone—H1F0—myocardium—coronary artery disease	0.000644	0.0123	CbGeAlD
Risperidone—HTR7—endothelium—coronary artery disease	0.000636	0.0121	CbGeAlD
Risperidone—Iloperidone—HTR7—coronary artery disease	0.000486	0.45	CrCbGaD
Risperidone—HTR2A—artery—coronary artery disease	0.00047	0.00897	CbGeAlD
Risperidone—H1F0—heart—coronary artery disease	0.00045	0.00858	CbGeAlD
Risperidone—H1F0—cardiovascular system—coronary artery disease	0.000424	0.0081	CbGeAlD
Risperidone—HTR2A—endothelium—coronary artery disease	0.000397	0.00757	CbGeAlD
Risperidone—KCNH2—cardiac ventricle—coronary artery disease	0.000394	0.00751	CbGeAlD
Risperidone—ADRA2C—cardiac ventricle—coronary artery disease	0.000388	0.00741	CbGeAlD
Risperidone—H1F0—cardiac atrium—coronary artery disease	0.000385	0.00734	CbGeAlD
Risperidone—KCNH2—myocardium—coronary artery disease	0.00037	0.00707	CbGeAlD
Risperidone—ADRA2C—myocardium—coronary artery disease	0.000365	0.00697	CbGeAlD
Risperidone—Paliperidone—HTR2A—coronary artery disease	0.00035	0.324	CrCbGaD
Risperidone—HTR1B—cardiovascular system—coronary artery disease	0.000339	0.00648	CbGeAlD
Risperidone—H1F0—blood—coronary artery disease	0.000336	0.0064	CbGeAlD
Risperidone—HTR1D—cardiovascular system—coronary artery disease	0.000329	0.00627	CbGeAlD
Risperidone—HTR2B—heart—coronary artery disease	0.000324	0.00618	CbGeAlD
Risperidone—HTR2B—cardiovascular system—coronary artery disease	0.000306	0.00584	CbGeAlD
Risperidone—HTR7—heart—coronary artery disease	0.000277	0.0053	CbGeAlD
Risperidone—HTR1A—cardiovascular system—coronary artery disease	0.000274	0.00523	CbGeAlD
Risperidone—ADRA1A—heart—coronary artery disease	0.000268	0.00511	CbGeAlD
Risperidone—HTR7—cardiovascular system—coronary artery disease	0.000262	0.005	CbGeAlD
Risperidone—KCNH2—heart—coronary artery disease	0.000258	0.00493	CbGeAlD
Risperidone—ADRA2C—heart—coronary artery disease	0.000255	0.00487	CbGeAlD
Risperidone—ADRA1A—cardiovascular system—coronary artery disease	0.000253	0.00482	CbGeAlD
Risperidone—Iloperidone—HTR2A—coronary artery disease	0.000245	0.226	CrCbGaD
Risperidone—KCNH2—cardiovascular system—coronary artery disease	0.000244	0.00466	CbGeAlD
Risperidone—HTR2B—blood—coronary artery disease	0.000242	0.00461	CbGeAlD
Risperidone—KCNH2—cardiac atrium—coronary artery disease	0.000221	0.00422	CbGeAlD
Risperidone—ADRA2C—cardiac atrium—coronary artery disease	0.000218	0.00416	CbGeAlD
Risperidone—HTR7—blood—coronary artery disease	0.000207	0.00395	CbGeAlD
Risperidone—ADRA2A—heart—coronary artery disease	0.000203	0.00388	CbGeAlD
Risperidone—ADRA1A—blood—coronary artery disease	0.0002	0.00381	CbGeAlD
Risperidone—KCNH2—blood—coronary artery disease	0.000193	0.00368	CbGeAlD
Risperidone—ADRA2C—blood—coronary artery disease	0.00019	0.00363	CbGeAlD
Risperidone—ADRA2A—cardiac atrium—coronary artery disease	0.000174	0.00332	CbGeAlD
Risperidone—HTR2A—heart—coronary artery disease	0.000173	0.0033	CbGeAlD
Risperidone—HTR2A—cardiovascular system—coronary artery disease	0.000163	0.00312	CbGeAlD
Risperidone—CYP3A5—blood—coronary artery disease	0.000159	0.00304	CbGeAlD
Risperidone—ADRA2A—blood—coronary artery disease	0.000152	0.0029	CbGeAlD
Risperidone—HTR2A—blood—coronary artery disease	0.000129	0.00246	CbGeAlD
Risperidone—CYP3A4—blood—coronary artery disease	0.00012	0.00228	CbGeAlD
Risperidone—CYP2D6—blood—coronary artery disease	0.000118	0.00225	CbGeAlD
Risperidone—ABCB1—heart—coronary artery disease	0.000113	0.00216	CbGeAlD
Risperidone—ABCB1—cardiovascular system—coronary artery disease	0.000107	0.00204	CbGeAlD
Risperidone—ABCB1—blood—coronary artery disease	8.46e-05	0.00161	CbGeAlD
Risperidone—Malaise—Lisinopril—coronary artery disease	2.33e-05	0.000121	CcSEcCtD
Risperidone—Oedema—Ramipril—coronary artery disease	2.32e-05	0.00012	CcSEcCtD
Risperidone—Anaphylactic shock—Ramipril—coronary artery disease	2.32e-05	0.00012	CcSEcCtD
Risperidone—Vertigo—Lisinopril—coronary artery disease	2.32e-05	0.00012	CcSEcCtD
Risperidone—Dry mouth—Timolol—coronary artery disease	2.31e-05	0.00012	CcSEcCtD
Risperidone—Pain—Losartan—coronary artery disease	2.31e-05	0.00012	CcSEcCtD
Risperidone—Constipation—Losartan—coronary artery disease	2.31e-05	0.00012	CcSEcCtD
Risperidone—Syncope—Lisinopril—coronary artery disease	2.31e-05	0.00012	CcSEcCtD
Risperidone—Vomiting—Eplerenone—coronary artery disease	2.31e-05	0.00012	CcSEcCtD
Risperidone—Feeling abnormal—Furosemide—coronary artery disease	2.31e-05	0.00012	CcSEcCtD
Risperidone—Leukopenia—Lisinopril—coronary artery disease	2.31e-05	0.00012	CcSEcCtD
Risperidone—Nausea—Fenofibrate—coronary artery disease	2.3e-05	0.00012	CcSEcCtD
Risperidone—Pruritus—Niacin—coronary artery disease	2.3e-05	0.000119	CcSEcCtD
Risperidone—Asthenia—Pravastatin—coronary artery disease	2.3e-05	0.000119	CcSEcCtD
Risperidone—Gastrointestinal pain—Furosemide—coronary artery disease	2.29e-05	0.000119	CcSEcCtD
Risperidone—Rash—Eplerenone—coronary artery disease	2.29e-05	0.000119	CcSEcCtD
Risperidone—Urticaria—Perindopril—coronary artery disease	2.29e-05	0.000119	CcSEcCtD
Risperidone—Hypersensitivity—Trandolapril—coronary artery disease	2.29e-05	0.000119	CcSEcCtD
Risperidone—Dermatitis—Eplerenone—coronary artery disease	2.29e-05	0.000119	CcSEcCtD
Risperidone—Diarrhoea—Valsartan—coronary artery disease	2.29e-05	0.000119	CcSEcCtD
Risperidone—Confusional state—Timolol—coronary artery disease	2.29e-05	0.000119	CcSEcCtD
Risperidone—Shock—Ramipril—coronary artery disease	2.28e-05	0.000118	CcSEcCtD
Risperidone—Hypersensitivity—Enalapril—coronary artery disease	2.28e-05	0.000118	CcSEcCtD
Risperidone—Body temperature increased—Perindopril—coronary artery disease	2.28e-05	0.000118	CcSEcCtD
Risperidone—Abdominal pain—Perindopril—coronary artery disease	2.28e-05	0.000118	CcSEcCtD
Risperidone—Palpitations—Lisinopril—coronary artery disease	2.28e-05	0.000118	CcSEcCtD
Risperidone—Diarrhoea—Olmesartan—coronary artery disease	2.28e-05	0.000118	CcSEcCtD
Risperidone—Headache—Eplerenone—coronary artery disease	2.28e-05	0.000118	CcSEcCtD
Risperidone—Nervous system disorder—Ramipril—coronary artery disease	2.28e-05	0.000118	CcSEcCtD
Risperidone—Thrombocytopenia—Ramipril—coronary artery disease	2.27e-05	0.000118	CcSEcCtD
Risperidone—Oedema—Timolol—coronary artery disease	2.27e-05	0.000118	CcSEcCtD
Risperidone—Anaphylactic shock—Timolol—coronary artery disease	2.27e-05	0.000118	CcSEcCtD
Risperidone—Pruritus—Pravastatin—coronary artery disease	2.27e-05	0.000118	CcSEcCtD
Risperidone—Loss of consciousness—Lisinopril—coronary artery disease	2.27e-05	0.000118	CcSEcCtD
Risperidone—Nausea—Clopidogrel—coronary artery disease	2.27e-05	0.000118	CcSEcCtD
Risperidone—Tachycardia—Ramipril—coronary artery disease	2.26e-05	0.000118	CcSEcCtD
Risperidone—Skin disorder—Ramipril—coronary artery disease	2.25e-05	0.000117	CcSEcCtD
Risperidone—Infection—Timolol—coronary artery disease	2.25e-05	0.000117	CcSEcCtD
Risperidone—Vomiting—Simvastatin—coronary artery disease	2.25e-05	0.000117	CcSEcCtD
Risperidone—Hypersensitivity—Telmisartan—coronary artery disease	2.25e-05	0.000117	CcSEcCtD
Risperidone—Cough—Lisinopril—coronary artery disease	2.25e-05	0.000117	CcSEcCtD
Risperidone—Nausea—Lovastatin—coronary artery disease	2.25e-05	0.000117	CcSEcCtD
Risperidone—Hyperhidrosis—Ramipril—coronary artery disease	2.24e-05	0.000116	CcSEcCtD
Risperidone—Rash—Simvastatin—coronary artery disease	2.23e-05	0.000116	CcSEcCtD
Risperidone—Dermatitis—Simvastatin—coronary artery disease	2.23e-05	0.000116	CcSEcCtD
Risperidone—Asthenia—Trandolapril—coronary artery disease	2.23e-05	0.000116	CcSEcCtD
Risperidone—Shock—Timolol—coronary artery disease	2.23e-05	0.000116	CcSEcCtD
Risperidone—Feeling abnormal—Losartan—coronary artery disease	2.23e-05	0.000116	CcSEcCtD
Risperidone—Urticaria—Furosemide—coronary artery disease	2.23e-05	0.000116	CcSEcCtD
Risperidone—Diarrhoea—Niacin—coronary artery disease	2.23e-05	0.000116	CcSEcCtD
Risperidone—Nervous system disorder—Timolol—coronary artery disease	2.22e-05	0.000115	CcSEcCtD
Risperidone—Asthenia—Enalapril—coronary artery disease	2.22e-05	0.000115	CcSEcCtD
Risperidone—Headache—Simvastatin—coronary artery disease	2.22e-05	0.000115	CcSEcCtD
Risperidone—Abdominal pain—Furosemide—coronary artery disease	2.22e-05	0.000115	CcSEcCtD
Risperidone—Body temperature increased—Furosemide—coronary artery disease	2.22e-05	0.000115	CcSEcCtD
Risperidone—Gastrointestinal pain—Losartan—coronary artery disease	2.21e-05	0.000115	CcSEcCtD
Risperidone—Dizziness—Valsartan—coronary artery disease	2.21e-05	0.000115	CcSEcCtD
Risperidone—Anorexia—Ramipril—coronary artery disease	2.21e-05	0.000115	CcSEcCtD
Risperidone—Nausea—Ezetimibe—coronary artery disease	2.21e-05	0.000115	CcSEcCtD
Risperidone—Skin disorder—Timolol—coronary artery disease	2.2e-05	0.000114	CcSEcCtD
Risperidone—Dizziness—Olmesartan—coronary artery disease	2.2e-05	0.000114	CcSEcCtD
Risperidone—Pruritus—Trandolapril—coronary artery disease	2.2e-05	0.000114	CcSEcCtD
Risperidone—Chest pain—Lisinopril—coronary artery disease	2.2e-05	0.000114	CcSEcCtD
Risperidone—Myalgia—Lisinopril—coronary artery disease	2.2e-05	0.000114	CcSEcCtD
Risperidone—Arthralgia—Lisinopril—coronary artery disease	2.2e-05	0.000114	CcSEcCtD
Risperidone—Hyperhidrosis—Timolol—coronary artery disease	2.19e-05	0.000114	CcSEcCtD
Risperidone—Asthenia—Telmisartan—coronary artery disease	2.19e-05	0.000114	CcSEcCtD
Risperidone—Pruritus—Enalapril—coronary artery disease	2.19e-05	0.000114	CcSEcCtD
Risperidone—Diarrhoea—Pravastatin—coronary artery disease	2.19e-05	0.000114	CcSEcCtD
Risperidone—Anxiety—Lisinopril—coronary artery disease	2.19e-05	0.000114	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.18e-05	0.000113	CcSEcCtD
Risperidone—Discomfort—Lisinopril—coronary artery disease	2.17e-05	0.000113	CcSEcCtD
Risperidone—Hypotension—Ramipril—coronary artery disease	2.17e-05	0.000113	CcSEcCtD
Risperidone—Anorexia—Timolol—coronary artery disease	2.16e-05	0.000112	CcSEcCtD
Risperidone—Pruritus—Telmisartan—coronary artery disease	2.16e-05	0.000112	CcSEcCtD
Risperidone—Nausea—Eplerenone—coronary artery disease	2.16e-05	0.000112	CcSEcCtD
Risperidone—Dizziness—Niacin—coronary artery disease	2.15e-05	0.000112	CcSEcCtD
Risperidone—Urticaria—Losartan—coronary artery disease	2.15e-05	0.000112	CcSEcCtD
Risperidone—Dry mouth—Lisinopril—coronary artery disease	2.15e-05	0.000111	CcSEcCtD
Risperidone—Abdominal pain—Losartan—coronary artery disease	2.14e-05	0.000111	CcSEcCtD
Risperidone—Body temperature increased—Losartan—coronary artery disease	2.14e-05	0.000111	CcSEcCtD
Risperidone—Asthenia—Captopril—coronary artery disease	2.13e-05	0.000111	CcSEcCtD
Risperidone—Diarrhoea—Trandolapril—coronary artery disease	2.13e-05	0.00011	CcSEcCtD
Risperidone—Vomiting—Valsartan—coronary artery disease	2.13e-05	0.00011	CcSEcCtD
Risperidone—Confusional state—Lisinopril—coronary artery disease	2.12e-05	0.00011	CcSEcCtD
Risperidone—Diarrhoea—Enalapril—coronary artery disease	2.12e-05	0.00011	CcSEcCtD
Risperidone—Hypotension—Timolol—coronary artery disease	2.12e-05	0.00011	CcSEcCtD
Risperidone—Dizziness—Pravastatin—coronary artery disease	2.12e-05	0.00011	CcSEcCtD
Risperidone—Vomiting—Olmesartan—coronary artery disease	2.12e-05	0.00011	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.11e-05	0.00011	CcSEcCtD
Risperidone—Rash—Valsartan—coronary artery disease	2.11e-05	0.000109	CcSEcCtD
Risperidone—Dermatitis—Valsartan—coronary artery disease	2.11e-05	0.000109	CcSEcCtD
Risperidone—Nausea—Simvastatin—coronary artery disease	2.1e-05	0.000109	CcSEcCtD
Risperidone—Oedema—Lisinopril—coronary artery disease	2.1e-05	0.000109	CcSEcCtD
Risperidone—Anaphylactic shock—Lisinopril—coronary artery disease	2.1e-05	0.000109	CcSEcCtD
Risperidone—Pruritus—Captopril—coronary artery disease	2.1e-05	0.000109	CcSEcCtD
Risperidone—Rash—Olmesartan—coronary artery disease	2.1e-05	0.000109	CcSEcCtD
Risperidone—Insomnia—Ramipril—coronary artery disease	2.1e-05	0.000109	CcSEcCtD
Risperidone—Dermatitis—Olmesartan—coronary artery disease	2.1e-05	0.000109	CcSEcCtD
Risperidone—Headache—Valsartan—coronary artery disease	2.1e-05	0.000109	CcSEcCtD
Risperidone—Diarrhoea—Telmisartan—coronary artery disease	2.09e-05	0.000108	CcSEcCtD
Risperidone—Infection—Lisinopril—coronary artery disease	2.09e-05	0.000108	CcSEcCtD
Risperidone—Headache—Olmesartan—coronary artery disease	2.09e-05	0.000108	CcSEcCtD
Risperidone—Paraesthesia—Ramipril—coronary artery disease	2.08e-05	0.000108	CcSEcCtD
Risperidone—Shock—Lisinopril—coronary artery disease	2.07e-05	0.000107	CcSEcCtD
Risperidone—Asthenia—Perindopril—coronary artery disease	2.07e-05	0.000107	CcSEcCtD
Risperidone—Dyspnoea—Ramipril—coronary artery disease	2.07e-05	0.000107	CcSEcCtD
Risperidone—Vomiting—Niacin—coronary artery disease	2.07e-05	0.000107	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Timolol—coronary artery disease	2.07e-05	0.000107	CcSEcCtD
Risperidone—Hypersensitivity—Furosemide—coronary artery disease	2.07e-05	0.000107	CcSEcCtD
Risperidone—Somnolence—Ramipril—coronary artery disease	2.06e-05	0.000107	CcSEcCtD
Risperidone—Thrombocytopenia—Lisinopril—coronary artery disease	2.06e-05	0.000107	CcSEcCtD
Risperidone—Dizziness—Trandolapril—coronary artery disease	2.06e-05	0.000107	CcSEcCtD
Risperidone—Tachycardia—Lisinopril—coronary artery disease	2.05e-05	0.000107	CcSEcCtD
Risperidone—Insomnia—Timolol—coronary artery disease	2.05e-05	0.000106	CcSEcCtD
Risperidone—Rash—Niacin—coronary artery disease	2.05e-05	0.000106	CcSEcCtD
Risperidone—Dermatitis—Niacin—coronary artery disease	2.05e-05	0.000106	CcSEcCtD
Risperidone—Dizziness—Enalapril—coronary artery disease	2.05e-05	0.000106	CcSEcCtD
Risperidone—Skin disorder—Lisinopril—coronary artery disease	2.04e-05	0.000106	CcSEcCtD
Risperidone—Dyspepsia—Ramipril—coronary artery disease	2.04e-05	0.000106	CcSEcCtD
Risperidone—Pruritus—Perindopril—coronary artery disease	2.04e-05	0.000106	CcSEcCtD
Risperidone—Headache—Niacin—coronary artery disease	2.04e-05	0.000106	CcSEcCtD
Risperidone—Paraesthesia—Timolol—coronary artery disease	2.04e-05	0.000106	CcSEcCtD
Risperidone—Vomiting—Pravastatin—coronary artery disease	2.04e-05	0.000106	CcSEcCtD
Risperidone—Hyperhidrosis—Lisinopril—coronary artery disease	2.03e-05	0.000106	CcSEcCtD
Risperidone—Diarrhoea—Captopril—coronary artery disease	2.03e-05	0.000105	CcSEcCtD
Risperidone—Dyspnoea—Timolol—coronary artery disease	2.02e-05	0.000105	CcSEcCtD
Risperidone—Dizziness—Telmisartan—coronary artery disease	2.02e-05	0.000105	CcSEcCtD
Risperidone—Rash—Pravastatin—coronary artery disease	2.02e-05	0.000105	CcSEcCtD
Risperidone—Dermatitis—Pravastatin—coronary artery disease	2.02e-05	0.000105	CcSEcCtD
Risperidone—Decreased appetite—Ramipril—coronary artery disease	2.02e-05	0.000105	CcSEcCtD
Risperidone—Somnolence—Timolol—coronary artery disease	2.02e-05	0.000105	CcSEcCtD
Risperidone—Asthenia—Furosemide—coronary artery disease	2.01e-05	0.000104	CcSEcCtD
Risperidone—Headache—Pravastatin—coronary artery disease	2.01e-05	0.000104	CcSEcCtD
Risperidone—Anorexia—Lisinopril—coronary artery disease	2.01e-05	0.000104	CcSEcCtD
Risperidone—Gastrointestinal disorder—Ramipril—coronary artery disease	2e-05	0.000104	CcSEcCtD
Risperidone—Fatigue—Ramipril—coronary artery disease	2e-05	0.000104	CcSEcCtD
Risperidone—Dyspepsia—Timolol—coronary artery disease	2e-05	0.000104	CcSEcCtD
Risperidone—Hypersensitivity—Losartan—coronary artery disease	1.99e-05	0.000103	CcSEcCtD
Risperidone—Nausea—Valsartan—coronary artery disease	1.99e-05	0.000103	CcSEcCtD
Risperidone—Pruritus—Furosemide—coronary artery disease	1.98e-05	0.000103	CcSEcCtD
Risperidone—Constipation—Ramipril—coronary artery disease	1.98e-05	0.000103	CcSEcCtD
Risperidone—Nausea—Olmesartan—coronary artery disease	1.98e-05	0.000103	CcSEcCtD
Risperidone—Vomiting—Trandolapril—coronary artery disease	1.98e-05	0.000103	CcSEcCtD
Risperidone—Diarrhoea—Perindopril—coronary artery disease	1.97e-05	0.000102	CcSEcCtD
Risperidone—Decreased appetite—Timolol—coronary artery disease	1.97e-05	0.000102	CcSEcCtD
Risperidone—Vomiting—Enalapril—coronary artery disease	1.97e-05	0.000102	CcSEcCtD
Risperidone—Hypotension—Lisinopril—coronary artery disease	1.97e-05	0.000102	CcSEcCtD
Risperidone—Dizziness—Captopril—coronary artery disease	1.97e-05	0.000102	CcSEcCtD
Risperidone—Rash—Trandolapril—coronary artery disease	1.96e-05	0.000102	CcSEcCtD
Risperidone—Dermatitis—Trandolapril—coronary artery disease	1.96e-05	0.000102	CcSEcCtD
Risperidone—Gastrointestinal disorder—Timolol—coronary artery disease	1.96e-05	0.000102	CcSEcCtD
Risperidone—Fatigue—Timolol—coronary artery disease	1.96e-05	0.000101	CcSEcCtD
Risperidone—Rash—Enalapril—coronary artery disease	1.95e-05	0.000101	CcSEcCtD
Risperidone—Dermatitis—Enalapril—coronary artery disease	1.95e-05	0.000101	CcSEcCtD
Risperidone—Headache—Trandolapril—coronary artery disease	1.95e-05	0.000101	CcSEcCtD
Risperidone—Vomiting—Telmisartan—coronary artery disease	1.94e-05	0.000101	CcSEcCtD
Risperidone—Asthenia—Losartan—coronary artery disease	1.94e-05	0.000101	CcSEcCtD
Risperidone—Headache—Enalapril—coronary artery disease	1.94e-05	0.000101	CcSEcCtD
Risperidone—Pain—Timolol—coronary artery disease	1.94e-05	0.000101	CcSEcCtD
Risperidone—Nausea—Niacin—coronary artery disease	1.93e-05	0.0001	CcSEcCtD
Risperidone—Rash—Telmisartan—coronary artery disease	1.93e-05	0.0001	CcSEcCtD
Risperidone—Dermatitis—Telmisartan—coronary artery disease	1.93e-05	9.99e-05	CcSEcCtD
Risperidone—Diarrhoea—Furosemide—coronary artery disease	1.92e-05	9.96e-05	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.92e-05	9.95e-05	CcSEcCtD
Risperidone—Pruritus—Losartan—coronary artery disease	1.91e-05	9.93e-05	CcSEcCtD
Risperidone—Headache—Telmisartan—coronary artery disease	1.91e-05	9.93e-05	CcSEcCtD
Risperidone—Feeling abnormal—Ramipril—coronary artery disease	1.91e-05	9.92e-05	CcSEcCtD
Risperidone—Dizziness—Perindopril—coronary artery disease	1.91e-05	9.9e-05	CcSEcCtD
Risperidone—Insomnia—Lisinopril—coronary artery disease	1.9e-05	9.88e-05	CcSEcCtD
Risperidone—Nausea—Pravastatin—coronary artery disease	1.9e-05	9.87e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Ramipril—coronary artery disease	1.9e-05	9.85e-05	CcSEcCtD
Risperidone—Paraesthesia—Lisinopril—coronary artery disease	1.89e-05	9.81e-05	CcSEcCtD
Risperidone—Vomiting—Captopril—coronary artery disease	1.89e-05	9.8e-05	CcSEcCtD
Risperidone—Dyspnoea—Lisinopril—coronary artery disease	1.88e-05	9.74e-05	CcSEcCtD
Risperidone—Rash—Captopril—coronary artery disease	1.87e-05	9.72e-05	CcSEcCtD
Risperidone—Dermatitis—Captopril—coronary artery disease	1.87e-05	9.71e-05	CcSEcCtD
Risperidone—Somnolence—Lisinopril—coronary artery disease	1.87e-05	9.71e-05	CcSEcCtD
Risperidone—Feeling abnormal—Timolol—coronary artery disease	1.87e-05	9.7e-05	CcSEcCtD
Risperidone—Headache—Captopril—coronary artery disease	1.86e-05	9.66e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Timolol—coronary artery disease	1.86e-05	9.63e-05	CcSEcCtD
Risperidone—Dizziness—Furosemide—coronary artery disease	1.85e-05	9.62e-05	CcSEcCtD
Risperidone—Dyspepsia—Lisinopril—coronary artery disease	1.85e-05	9.61e-05	CcSEcCtD
Risperidone—Diarrhoea—Losartan—coronary artery disease	1.85e-05	9.61e-05	CcSEcCtD
Risperidone—Nausea—Trandolapril—coronary artery disease	1.85e-05	9.59e-05	CcSEcCtD
Risperidone—Urticaria—Ramipril—coronary artery disease	1.84e-05	9.57e-05	CcSEcCtD
Risperidone—Nausea—Enalapril—coronary artery disease	1.84e-05	9.55e-05	CcSEcCtD
Risperidone—Vomiting—Perindopril—coronary artery disease	1.83e-05	9.52e-05	CcSEcCtD
Risperidone—Body temperature increased—Ramipril—coronary artery disease	1.83e-05	9.52e-05	CcSEcCtD
Risperidone—Abdominal pain—Ramipril—coronary artery disease	1.83e-05	9.52e-05	CcSEcCtD
Risperidone—Decreased appetite—Lisinopril—coronary artery disease	1.83e-05	9.49e-05	CcSEcCtD
Risperidone—Rash—Perindopril—coronary artery disease	1.82e-05	9.44e-05	CcSEcCtD
Risperidone—Dermatitis—Perindopril—coronary artery disease	1.82e-05	9.43e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.82e-05	9.43e-05	CcSEcCtD
Risperidone—Nausea—Telmisartan—coronary artery disease	1.82e-05	9.42e-05	CcSEcCtD
Risperidone—Fatigue—Lisinopril—coronary artery disease	1.81e-05	9.41e-05	CcSEcCtD
Risperidone—Headache—Perindopril—coronary artery disease	1.81e-05	9.38e-05	CcSEcCtD
Risperidone—Urticaria—Timolol—coronary artery disease	1.8e-05	9.35e-05	CcSEcCtD
Risperidone—Constipation—Lisinopril—coronary artery disease	1.8e-05	9.34e-05	CcSEcCtD
Risperidone—Pain—Lisinopril—coronary artery disease	1.8e-05	9.34e-05	CcSEcCtD
Risperidone—Abdominal pain—Timolol—coronary artery disease	1.79e-05	9.31e-05	CcSEcCtD
Risperidone—Body temperature increased—Timolol—coronary artery disease	1.79e-05	9.31e-05	CcSEcCtD
Risperidone—Dizziness—Losartan—coronary artery disease	1.79e-05	9.29e-05	CcSEcCtD
Risperidone—Vomiting—Furosemide—coronary artery disease	1.78e-05	9.25e-05	CcSEcCtD
Risperidone—Rash—Furosemide—coronary artery disease	1.77e-05	9.18e-05	CcSEcCtD
Risperidone—Dermatitis—Furosemide—coronary artery disease	1.77e-05	9.17e-05	CcSEcCtD
Risperidone—Nausea—Captopril—coronary artery disease	1.77e-05	9.16e-05	CcSEcCtD
Risperidone—Headache—Furosemide—coronary artery disease	1.76e-05	9.12e-05	CcSEcCtD
Risperidone—Feeling abnormal—Lisinopril—coronary artery disease	1.73e-05	9e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Lisinopril—coronary artery disease	1.72e-05	8.93e-05	CcSEcCtD
Risperidone—Vomiting—Losartan—coronary artery disease	1.72e-05	8.93e-05	CcSEcCtD
Risperidone—Nausea—Perindopril—coronary artery disease	1.71e-05	8.89e-05	CcSEcCtD
Risperidone—Hypersensitivity—Ramipril—coronary artery disease	1.71e-05	8.87e-05	CcSEcCtD
Risperidone—Rash—Losartan—coronary artery disease	1.71e-05	8.85e-05	CcSEcCtD
Risperidone—Dermatitis—Losartan—coronary artery disease	1.7e-05	8.85e-05	CcSEcCtD
Risperidone—Headache—Losartan—coronary artery disease	1.7e-05	8.8e-05	CcSEcCtD
Risperidone—Urticaria—Lisinopril—coronary artery disease	1.67e-05	8.67e-05	CcSEcCtD
Risperidone—Hypersensitivity—Timolol—coronary artery disease	1.67e-05	8.67e-05	CcSEcCtD
Risperidone—Nausea—Furosemide—coronary artery disease	1.67e-05	8.64e-05	CcSEcCtD
Risperidone—Asthenia—Ramipril—coronary artery disease	1.66e-05	8.64e-05	CcSEcCtD
Risperidone—Abdominal pain—Lisinopril—coronary artery disease	1.66e-05	8.63e-05	CcSEcCtD
Risperidone—Body temperature increased—Lisinopril—coronary artery disease	1.66e-05	8.63e-05	CcSEcCtD
Risperidone—Pruritus—Ramipril—coronary artery disease	1.64e-05	8.52e-05	CcSEcCtD
Risperidone—Asthenia—Timolol—coronary artery disease	1.63e-05	8.45e-05	CcSEcCtD
Risperidone—Nausea—Losartan—coronary artery disease	1.61e-05	8.34e-05	CcSEcCtD
Risperidone—Pruritus—Timolol—coronary artery disease	1.61e-05	8.33e-05	CcSEcCtD
Risperidone—Diarrhoea—Ramipril—coronary artery disease	1.59e-05	8.24e-05	CcSEcCtD
Risperidone—Diarrhoea—Timolol—coronary artery disease	1.55e-05	8.05e-05	CcSEcCtD
Risperidone—Hypersensitivity—Lisinopril—coronary artery disease	1.55e-05	8.05e-05	CcSEcCtD
Risperidone—Dizziness—Ramipril—coronary artery disease	1.53e-05	7.96e-05	CcSEcCtD
Risperidone—Asthenia—Lisinopril—coronary artery disease	1.51e-05	7.83e-05	CcSEcCtD
Risperidone—Dizziness—Timolol—coronary artery disease	1.5e-05	7.78e-05	CcSEcCtD
Risperidone—Pruritus—Lisinopril—coronary artery disease	1.49e-05	7.73e-05	CcSEcCtD
Risperidone—Vomiting—Ramipril—coronary artery disease	1.48e-05	7.66e-05	CcSEcCtD
Risperidone—Rash—Ramipril—coronary artery disease	1.46e-05	7.59e-05	CcSEcCtD
Risperidone—Dermatitis—Ramipril—coronary artery disease	1.46e-05	7.58e-05	CcSEcCtD
Risperidone—Headache—Ramipril—coronary artery disease	1.45e-05	7.54e-05	CcSEcCtD
Risperidone—Vomiting—Timolol—coronary artery disease	1.44e-05	7.48e-05	CcSEcCtD
Risperidone—Diarrhoea—Lisinopril—coronary artery disease	1.44e-05	7.47e-05	CcSEcCtD
Risperidone—Rash—Timolol—coronary artery disease	1.43e-05	7.42e-05	CcSEcCtD
Risperidone—Dermatitis—Timolol—coronary artery disease	1.43e-05	7.41e-05	CcSEcCtD
Risperidone—Headache—Timolol—coronary artery disease	1.42e-05	7.37e-05	CcSEcCtD
Risperidone—Dizziness—Lisinopril—coronary artery disease	1.39e-05	7.22e-05	CcSEcCtD
Risperidone—Nausea—Ramipril—coronary artery disease	1.38e-05	7.15e-05	CcSEcCtD
Risperidone—Nausea—Timolol—coronary artery disease	1.35e-05	6.99e-05	CcSEcCtD
Risperidone—Vomiting—Lisinopril—coronary artery disease	1.34e-05	6.94e-05	CcSEcCtD
Risperidone—Rash—Lisinopril—coronary artery disease	1.33e-05	6.89e-05	CcSEcCtD
Risperidone—Dermatitis—Lisinopril—coronary artery disease	1.33e-05	6.88e-05	CcSEcCtD
Risperidone—Headache—Lisinopril—coronary artery disease	1.32e-05	6.84e-05	CcSEcCtD
Risperidone—Nausea—Lisinopril—coronary artery disease	1.25e-05	6.49e-05	CcSEcCtD
Risperidone—HTR2B—Signaling Pathways—VEGFA—coronary artery disease	1.11e-06	9.95e-06	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	1.11e-06	9.94e-06	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.11e-06	9.94e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	1.11e-06	9.93e-06	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TGFB1—coronary artery disease	1.11e-06	9.93e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	1.11e-06	9.92e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AGT—coronary artery disease	1.11e-06	9.91e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	1.1e-06	9.88e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	1.1e-06	9.87e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	1.1e-06	9.85e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	1.1e-06	9.84e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.1e-06	9.83e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NOS3—coronary artery disease	1.1e-06	9.83e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—FGF2—coronary artery disease	1.09e-06	9.81e-06	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MAPK1—coronary artery disease	1.09e-06	9.8e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—FGF2—coronary artery disease	1.09e-06	9.79e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	1.09e-06	9.78e-06	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MAPK1—coronary artery disease	1.09e-06	9.73e-06	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	1.08e-06	9.72e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—APOE—coronary artery disease	1.08e-06	9.71e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	1.08e-06	9.71e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NOS3—coronary artery disease	1.08e-06	9.67e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	1.08e-06	9.66e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NOS3—coronary artery disease	1.08e-06	9.65e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—NOS3—coronary artery disease	1.08e-06	9.64e-06	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTGS2—coronary artery disease	1.07e-06	9.63e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	1.07e-06	9.61e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	1.07e-06	9.6e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—APOA1—coronary artery disease	1.07e-06	9.6e-06	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	1.07e-06	9.59e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	1.07e-06	9.59e-06	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TGFB1—coronary artery disease	1.07e-06	9.56e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—JAK2—coronary artery disease	1.07e-06	9.55e-06	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	1.07e-06	9.55e-06	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	1.06e-06	9.53e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CASP3—coronary artery disease	1.06e-06	9.51e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	1.06e-06	9.47e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	1.06e-06	9.46e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CASP3—coronary artery disease	1.06e-06	9.46e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—IL6—coronary artery disease	1.05e-06	9.44e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—JAK2—coronary artery disease	1.05e-06	9.4e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—IL6—coronary artery disease	1.05e-06	9.4e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.05e-06	9.39e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—JAK2—coronary artery disease	1.05e-06	9.38e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—VEGFA—coronary artery disease	1.05e-06	9.38e-06	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MAPK1—coronary artery disease	1.05e-06	9.38e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	1.05e-06	9.36e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AGT—coronary artery disease	1.04e-06	9.34e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	1.04e-06	9.31e-06	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	1.04e-06	9.28e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—VEGFA—coronary artery disease	1.03e-06	9.26e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CCND1—coronary artery disease	1.03e-06	9.25e-06	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.03e-06	9.23e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	1.03e-06	9.22e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.03e-06	9.21e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CCND1—coronary artery disease	1.03e-06	9.21e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	1.03e-06	9.21e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	1.03e-06	9.2e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	1.03e-06	9.19e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—APOE—coronary artery disease	1.02e-06	9.15e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	1.02e-06	9.14e-06	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	1.02e-06	9.14e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	1.02e-06	9.13e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.02e-06	9.1e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	1.01e-06	9.05e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—APOA1—coronary artery disease	1.01e-06	9.05e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	1.01e-06	9.03e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	1.01e-06	9.02e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	1e-06	8.99e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MMP9—coronary artery disease	1e-06	8.98e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	9.99e-07	8.95e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	9.99e-07	8.95e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MMP9—coronary artery disease	9.98e-07	8.94e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	9.96e-07	8.92e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTGS2—coronary artery disease	9.85e-07	8.82e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GGT1—coronary artery disease	9.84e-07	8.81e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GOT1—coronary artery disease	9.84e-07	8.81e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	9.84e-07	8.81e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	9.82e-07	8.8e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CXCL8—coronary artery disease	9.73e-07	8.72e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	9.73e-07	8.71e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	9.7e-07	8.69e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	9.68e-07	8.67e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TGFB1—coronary artery disease	9.61e-07	8.61e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	9.58e-07	8.58e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CXCL8—coronary artery disease	9.56e-07	8.56e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	9.55e-07	8.56e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	9.55e-07	8.55e-06	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—PIK3CA—coronary artery disease	9.49e-07	8.5e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TGFB1—coronary artery disease	9.48e-07	8.5e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PPARG—coronary artery disease	9.45e-07	8.46e-06	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	9.43e-07	8.45e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MAPK1—coronary artery disease	9.43e-07	8.44e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	9.41e-07	8.43e-06	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	9.4e-07	8.42e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	9.38e-07	8.4e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	9.36e-07	8.38e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	9.33e-07	8.36e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CASP3—coronary artery disease	9.32e-07	8.35e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—POMC—coronary artery disease	9.32e-07	8.35e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MAPK1—coronary artery disease	9.3e-07	8.33e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	9.26e-07	8.3e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL6—coronary artery disease	9.26e-07	8.29e-06	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	9.25e-07	8.29e-06	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	9.23e-07	8.27e-06	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	9.23e-07	8.27e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CASP3—coronary artery disease	9.17e-07	8.21e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CASP3—coronary artery disease	9.15e-07	8.19e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL6—coronary artery disease	9.11e-07	8.16e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL6—coronary artery disease	9.09e-07	8.14e-06	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—PIK3CA—coronary artery disease	9.09e-07	8.14e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCND1—coronary artery disease	9.07e-07	8.12e-06	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	9.06e-07	8.12e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	9e-07	8.07e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	8.98e-07	8.04e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	8.96e-07	8.03e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCND1—coronary artery disease	8.92e-07	7.99e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	8.92e-07	7.99e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCND1—coronary artery disease	8.9e-07	7.98e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PPARG—coronary artery disease	8.9e-07	7.97e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTP1—coronary artery disease	8.84e-07	7.92e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MMP9—coronary artery disease	8.8e-07	7.89e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—POMC—coronary artery disease	8.78e-07	7.86e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	8.75e-07	7.84e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	8.74e-07	7.83e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—HMOX1—coronary artery disease	8.71e-07	7.81e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	8.71e-07	7.81e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	8.71e-07	7.81e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	8.67e-07	7.77e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MMP9—coronary artery disease	8.66e-07	7.76e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MMP9—coronary artery disease	8.64e-07	7.74e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CAT—coronary artery disease	8.6e-07	7.7e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	8.58e-07	7.68e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	8.56e-07	7.67e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—AKT1—coronary artery disease	8.54e-07	7.65e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—ALB—coronary artery disease	8.49e-07	7.61e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	8.48e-07	7.6e-06	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	8.42e-07	7.54e-06	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL6—coronary artery disease	8.4e-07	7.53e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	8.4e-07	7.53e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	8.4e-07	7.52e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—AKT1—coronary artery disease	8.38e-07	7.51e-06	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PIK3CA—coronary artery disease	8.38e-07	7.51e-06	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL6—coronary artery disease	8.35e-07	7.48e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOB—coronary artery disease	8.35e-07	7.48e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	8.34e-07	7.47e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	8.29e-07	7.42e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	8.27e-07	7.4e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	8.23e-07	7.37e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	8.22e-07	7.37e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	8.18e-07	7.33e-06	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL6—coronary artery disease	8.18e-07	7.32e-06	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PIK3CA—coronary artery disease	8.14e-07	7.29e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—NOS3—coronary artery disease	8.12e-07	7.28e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTM1—coronary artery disease	8.12e-07	7.27e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	8.12e-07	7.27e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	8.11e-07	7.26e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	8.07e-07	7.23e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	8.06e-07	7.22e-06	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL6—coronary artery disease	8.05e-07	7.21e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ALB—coronary artery disease	8e-07	7.17e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	8e-07	7.16e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—LPL—coronary artery disease	7.97e-07	7.14e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—coronary artery disease	7.91e-07	7.08e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	7.88e-07	7.06e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	7.87e-07	7.05e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	7.84e-07	7.03e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	7.78e-07	6.97e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GPX1—coronary artery disease	7.78e-07	6.97e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—coronary artery disease	7.76e-07	6.95e-06	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—AKT1—coronary artery disease	7.75e-07	6.95e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	7.72e-07	6.91e-06	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—AKT1—coronary artery disease	7.7e-07	6.9e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL6—coronary artery disease	7.68e-07	6.88e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—NOS3—coronary artery disease	7.66e-07	6.86e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	7.64e-07	6.85e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	7.62e-07	6.82e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CD36—coronary artery disease	7.57e-07	6.78e-06	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—AKT1—coronary artery disease	7.54e-07	6.76e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	7.48e-07	6.7e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTGS2—coronary artery disease	7.43e-07	6.66e-06	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AKT1—coronary artery disease	7.42e-07	6.65e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	7.29e-07	6.53e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TGFB1—coronary artery disease	7.26e-07	6.5e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL6—coronary artery disease	7.24e-07	6.49e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MTHFR—coronary artery disease	7.18e-07	6.43e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL6—coronary artery disease	7.15e-07	6.4e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	7.14e-07	6.4e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TGFB1—coronary artery disease	7.12e-07	6.38e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MAPK1—coronary artery disease	7.12e-07	6.38e-06	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AKT1—coronary artery disease	7.09e-07	6.35e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	7.08e-07	6.34e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	7.03e-07	6.3e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	7e-07	6.27e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTGS2—coronary artery disease	7e-07	6.27e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	7e-07	6.27e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	6.99e-07	6.26e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MAPK1—coronary artery disease	6.99e-07	6.26e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	6.86e-07	6.14e-06	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AKT1—coronary artery disease	6.85e-07	6.13e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AGT—coronary artery disease	6.82e-07	6.11e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	6.81e-07	6.1e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	6.7e-07	6e-06	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AKT1—coronary artery disease	6.68e-07	5.99e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOE—coronary artery disease	6.68e-07	5.99e-06	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AKT1—coronary artery disease	6.65e-07	5.96e-06	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PIK3CA—coronary artery disease	6.61e-07	5.92e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOA1—coronary artery disease	6.6e-07	5.92e-06	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AKT1—coronary artery disease	6.59e-07	5.91e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	6.5e-07	5.82e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL6—coronary artery disease	6.45e-07	5.78e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	6.37e-07	5.71e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL6—coronary artery disease	6.23e-07	5.58e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL6—coronary artery disease	6.2e-07	5.55e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	6.18e-07	5.53e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	6.08e-07	5.44e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	6.06e-07	5.43e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PIK3CA—coronary artery disease	6.06e-07	5.43e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL6—coronary artery disease	6.03e-07	5.4e-06	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	5.95e-07	5.33e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	5.95e-07	5.33e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL6—coronary artery disease	5.93e-07	5.31e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARG—coronary artery disease	5.82e-07	5.21e-06	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AKT1—coronary artery disease	5.75e-07	5.15e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—POMC—coronary artery disease	5.74e-07	5.14e-06	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AKT1—coronary artery disease	5.72e-07	5.12e-06	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	5.56e-07	4.98e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	5.53e-07	4.95e-06	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	5.47e-07	4.9e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL6—coronary artery disease	5.47e-07	4.9e-06	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AKT1—coronary artery disease	5.4e-07	4.84e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL6—coronary artery disease	5.38e-07	4.82e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL6—coronary artery disease	5.37e-07	4.81e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL6—coronary artery disease	5.27e-07	4.72e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ALB—coronary artery disease	5.23e-07	4.69e-06	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AKT1—coronary artery disease	5.04e-07	4.52e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—NOS3—coronary artery disease	5.01e-07	4.48e-06	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AKT1—coronary artery disease	4.96e-07	4.45e-06	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AKT1—coronary artery disease	4.95e-07	4.44e-06	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AKT1—coronary artery disease	4.95e-07	4.43e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6—coronary artery disease	4.9e-07	4.39e-06	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	4.86e-07	4.35e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS2—coronary artery disease	4.58e-07	4.1e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CA—coronary artery disease	4.57e-07	4.1e-06	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	4.52e-07	4.05e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CA—coronary artery disease	4.31e-07	3.86e-06	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AKT1—coronary artery disease	3.73e-07	3.35e-06	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AKT1—coronary artery disease	3.52e-07	3.15e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.82e-07	2.52e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AKT1—coronary artery disease	2.3e-07	2.06e-06	CbGpPWpGaD
